Proteinea
Latest round
- Seed
Last raised
- Feb 2021
Total raised
- Undisclosed
Investors
- 2
About Proteinea
Founded in 2019 in Cairo, Egypt, Proteinea develops next-generation antibodies through AI-driven methods.Proteinea specializes in the engineering of next-generation antibodies through the application of proprietary AI models and computational tools. Their core product offerings focus on rationally designed antibody Fc domains that enable context-specific immune tuning, enhanced half-life, and targeted biodistribution. The company’s design frameworks integrate AI-driven predictions with therapeutic insights, aimed at unlocking differentiated immune functions. Proteinea's innovations are tailored for use in life-threatening diseases, catering primarily to biopharmaceutical companies and research institutions involved in the development of novel therapies.Proteinea generates revenue through strategic partnerships and collaborations with biopharmaceutical companies and research institutions. The company’s business model often revolves around B2B transactions, focusing on the licensing of their proprietary technologies and custom antibody design services. Clients typically engage in contractual agreements that may involve milestone payments associated with research and development phases. This transaction structure allows for flexible pricing arrangements based on the specific services rendered, which may include comprehensive antibody engineering packages.09 mn to enhance its research and development capabilities, focusing on launching new antibody products targeted for specific life-threatening diseases. The company aims to expand its market reach into Asia by 2023, enhancing its engagement with biotech firms and research institutions in this region.
Who invested in Proteinea
2 investors across 1 round
See all investors in Proteinea
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 26, 2021
Amount
Undisclosed
Investors
Questions about Proteinea
Who invested in Proteinea?
Proteinea has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proteinea raised?
Proteinea has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Proteinea last raise money?
Proteinea's most recent round on record is a Seed, in Feb 2021.
What does Proteinea do?
Founded in 2019 in Cairo, Egypt, Proteinea develops next-generation antibodies through AI-driven methods.
Where is Proteinea headquartered?
Proteinea is headquartered in Cairo, Egypt.
Which VCs invest in companies like Proteinea?
Among active investors with capital left to deploy, WestBridge Capital Partners, Ventures Platform, Persistent Energy Capital and Norrsken22 back biotechnology companies at Proteinea's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Proteinea? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.